Work

A phase I study of AMN107 alone and in combination with imatinib in patients (pts) with imatinib-resistant gastrointestinal stromal tumors (GIST)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.9545

Authors: P. Reichardt, P. G. Casali, J. Blay, M. Von Mehren, P. Schoffski, S. Hosseinzadeh, C. Tanaka, T. Gsponer, M. L. Veronese, G. D. Demetri

Institutions: Novartis (Switzerland), Fox Chase Cancer Center, Centre Léon Bérard, Dana-Farber Cancer Institute, Hôpital Edouard Herriot, Charité - Universitätsmedizin Berlin, KU Leuven

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3010765359

Cites:

Cited by: 11

Related to: 10